Related by context. All words. (Click for frequent words.) 73 androgen deficiency 71 urinary symptoms 70 urinary tract symptoms 69 comorbid conditions 69 dyspareunia 69 OAB symptoms 68 urinary tract symptoms LUTS 67 nocturia 67 dysuria 66 prostate cancer CaP 66 subclinical hypothyroidism 66 psychiatric comorbidities 66 overactive bladder symptoms 66 vasomotor symptoms 65 detrusor overactivity 65 perioperative complications 65 atrophic gastritis 65 MetS 65 hip BMD 65 somatic symptoms 65 chronic prostatitis 65 chronic prostatitis chronic 65 nonvertebral fractures 65 vaginal atrophy 65 androgen deprivation 65 abdominal adiposity 64 T2DM 64 autonomic dysfunction 64 HRQOL 64 HRQL 64 post thrombotic syndrome 64 carotid stenosis 64 urolithiasis 64 thyroid dysfunction 64 knee OA 64 cerebral microbleeds 64 azoospermia 64 colorectal adenoma 64 psychiatric comorbidity 64 undergoing radical prostatectomy 64 voiding dysfunction 64 dysmenorrhea 64 Heavy menstrual bleeding 63 serum testosterone 63 premenstrual syndrome PMS 63 GnRH agonists 63 β blockers 63 menopausal symptom 63 benign prostatic hypertrophy 63 postoperative AF 63 amenorrhea 63 comorbidity 63 systolic hypertension 63 EBRT 63 prolactin levels 63 thromboembolic 63 erection hardness 63 neurocognitive deficits 63 lipid lowering agents 63 extrapyramidal symptoms 63 vulvovaginal atrophy 63 varicocele 63 psychiatric morbidity 63 alexithymia 63 carotid IMT 63 RLS symptoms 63 Venous thromboembolism 63 hematuria 63 atherogenic dyslipidemia 63 HRQoL 63 loop diuretics 63 decreased libido 63 OSAHS 63 CLBP 62 endometrial carcinoma 62 comorbidities 62 knee osteoarthritis OA 62 urethral stricture 62 Subgroup analyzes 62 urinary incontinence UI 62 diabetes mellitus DM 62 fibromyalgia syndrome 62 depressive symptomatology 62 cervicitis 62 Nocturia 62 overactive bladder OAB symptoms 62 endometrial hyperplasia 62 subclinical atherosclerosis 62 dietary calcium intake 62 acetabular dysplasia 62 serum PTH 62 chronic pelvic 62 acute urinary retention 62 loop diuretic 62 vasomotor 62 varicoceles 62 polycystic ovary syndrome PCOS 62 hypogonadal 62 TURP 62 retrograde ejaculation 62 CVD mortality 62 thyrotropin levels 62 primary aldosteronism 62 recurrent miscarriage 62 flutamide 62 perimenopausal women 62 prostatitis 62 LHRH agonists 62 plus medroxyprogesterone acetate 62 posttreatment 62 recurrent VTE 62 BPH LUTS 62 neuropathic 62 atypical ductal hyperplasia 62 adjunctive ABILIFY 62 GERD symptoms 62 TEAEs 62 serum lipid levels 62 emotional lability 62 atypical hyperplasia 62 microscopic hematuria 62 intact parathyroid hormone 61 nasal obstruction 61 glucocorticoid therapy 61 thromboembolic disease 61 anticholinergic medications 61 radical prostatectomy RP 61 microalbuminuria 61 Sociodemographic 61 coronary calcification 61 fragility fracture 61 periprocedural MI 61 cyclic HMB 61 knee osteoarthritis 61 Comorbidities 61 abnormal uterine bleeding 61 hypopituitarism 61 heavy menstrual bleeding 61 neurocognitive impairment 61 symptomatic benign prostatic 61 hypogonadotropic hypogonadism 61 leiomyomas 61 Benign Prostatic Hyperplasia BPH 61 T2 lesions 61 hyperplasia BPH 61 GH deficiency 61 vertebral fracture 61 CHD mortality 61 prostatic hyperplasia 61 renal artery stenosis 61 Hypoactive Sexual Desire Disorder 61 subtrochanteric 61 sexual dysfunctions 61 arthralgias 61 PsA 61 plasma folate 61 conjunctival hyperemia 61 comorbid disorders 61 abdominal distension 61 logistic regression model 61 androgen suppression 61 NNT = 61 venlafaxine Effexor 61 benign prostatic hypertrophy BPH 61 solifenacin 61 T1DM 61 advanced adenoma 61 dyslipidaemia 61 symptomatic fibroids 61 urinary incontinence 61 benign prostatic hyperplasia 61 gallstone disease 61 amenorrhoea 61 artery stenosis 61 symptomatic hyponatremia 61 univariate analyzes 61 nonalcoholic steatohepatitis NASH 61 beta blocker therapy 61 hirsutism 61 intracranial hypertension 61 hallux valgus 61 sociodemographic characteristics 61 interstitial cystitis 61 serum PSA 61 androgen ablation 61 neurological abnormalities 61 urothelial carcinoma 61 serum testosterone levels 61 comorbid anxiety 61 aminotransferases 60 treat benign prostatic 60 ALT flares 60 hypertension diabetes mellitus 60 Testosterone deficiency 60 dysglycemia 60 left ventricular diastolic 60 hypercalciuria 60 collagenous colitis 60 antiarrhythmic drug 60 F FDG PET 60 postoperative mortality 60 covariate 60 neurocognitive function 60 mucosal inflammation 60 Sleep disordered breathing 60 clomipramine 60 renal tumors 60 testosterone supplementation 60 dysmenorrhoea 60 QoL 60 climacteric symptoms 60 somatoform disorders 60 postoperative complication 60 proton MR spectroscopy 60 pathologic fractures 60 syndromal 60 macroalbuminuria 60 SGPT 60 primary hyperparathyroidism 60 serum estradiol 60 osteoarthritic 60 HGPIN 60 radiographic findings 60 calcaneal fractures 60 histologically confirmed 60 comorbid depression 60 affective psychoses 60 liver histology 60 AVODART 60 bacterial prostatitis 60 oxycodone CR 60 tamsulosin 60 biochemical recurrence 60 serum concentrations 60 CI #.#-#.# [001] 60 adnexal mass 60 POAG 60 neuropsychiatric symptoms 60 adenomatous polyps 60 serum phosphate 60 variceal bleeding 60 reflux symptoms 60 tumor histology 60 cerebral infarction 60 postoperative delirium 60 femoral neck BMD 60 testosterone deficiency 60 bosentan 60 PONV 60 primary dysmenorrhea 60 hyperalgesia 60 abnormal vaginal bleeding 60 BPH symptoms 60 parkinsonism 60 poststroke 60 elevated triglyceride levels 60 Generalized Anxiety Disorder 60 proctitis 60 thromboembolic events 60 nondepressed 60 epididymitis 60 Depressive symptoms 60 premenstrual symptoms 60 pulmonary hypertension PH 60 breast tenderness 60 Hypogonadism 60 bilateral oophorectomy 60 dosage regimens 60 CP CPPS 60 prednisone prednisolone 60 Major Depressive Disorder 60 coronary stenosis 60 echocardiographic parameters 60 nonmetastatic prostate cancer 60 thromboembolism 60 choroidal neovascularization 60 SRBD 60 vascular dysfunction 60 reflux esophagitis 60 sonographic appearance 60 WOMAC pain 60 nonischemic 60 advanced neoplasia 60 microbleeds 60 menstrual pain 60 amisulpride 59 renal impairment 59 Radical prostatectomy 59 definite stent thrombosis 59 left ventricular dysfunction 59 nulliparous women 59 urodynamic 59 prodromal symptoms 59 radicular pain 59 dysfunctional voiding 59 adenotonsillectomy 59 Cognitive impairment 59 anal incontinence 59 pre menopausal 59 relapsed MM 59 irregular menstrual cycles 59 aminotransferase levels 59 chorioamnionitis 59 ejaculatory dysfunction 59 typical antipsychotics 59 hyperhomocysteinemia 59 plasma homocysteine 59 chronic musculoskeletal 59 SLNB 59 adrenalectomy 59 gastric cardia 59 phytoestrogen intake 59 fibroids endometriosis 59 polyarticular 59 arterial thromboembolic events 59 NATRECOR ® 59 Logistic regression 59 Comorbidity 59 impaired cognition 59 serum calcium levels 59 hypomagnesemia 59 occlusive disease 59 functional dyspepsia 59 serum cortisol 59 premorbid 59 hematologic toxicity 59 etiologic 59 gastrointestinal adverse reactions 59 chronicity 59 contrast induced nephropathy 59 hypercalcemia 59 Symptom severity 59 endometrial thickness 59 external beam radiotherapy 59 neuropsychological functioning 59 menorrhagia 59 chlamydial infection 59 multivariate analyzes 59 premenstrual dysphoric disorder PMDD 59 HMG CoA reductase inhibitors 59 BPS IC 59 serum urate levels 59 elevated serum creatinine 59 tertiles 59 coronary artery calcification 59 moderate renal impairment 59 aspartate aminotransferase AST 59 irregular menses 59 nonadherence 59 comorbid 59 hepatic lesions 59 postmenopausal hormone 59 estrogen deficiency 59 subfertility 59 generalized anxiety disorder GAD 59 intravesical therapy 59 chronic pancreatitis 59 stable angina 59 HoLEP 59 FSAD 59 thromboembolic complications 59 pentoxifylline 59 monoclonal gammopathy 59 Secondary efficacy endpoints 59 multivariable analyzes 59 LV dysfunction 59 femoral shaft fractures 59 morphometric vertebral fractures 59 postoperative morbidity 59 claudication 59 nephron sparing surgery 59 hyperintense lesions 59 adjunctive placebo 59 BMI z 59 detrusor 59 DPNP 59 Excessive daytime sleepiness 59 antidepressant efficacy 59 symptom severity 59 albuminuria 59 nonoperative treatment 59 Prehypertension 59 QTc interval 59 Sjögren syndrome 59 COPD exacerbations 59 MMSE scores 59 femoral neck fracture 59 bacteriuria 59 Benign Prostatic Hyperplasia 59 tolterodine 59 venous thrombosis 59 nonvertebral fracture 59 serum vitamin D 59 antiemetics 59 premenopausal women 59 urinary retention 59 HSDD 59 conjugated equine estrogen 59 antioxidant supplementation 59 hematological parameters 59 PCa 59 biologic DMARD 59 affective disorders 59 antidiabetic medication 59 salivary flow 59 confidence interval #.#-#.# 59 alpha blockers 59 thiazide diuretic 59 menstrual irregularities 59 APTIVUS r 59 symptomatic BPH 59 systemic corticosteroid 59 left ventricular systolic 59 dyspnoea 59 mild renal insufficiency 59 bioavailable testosterone 59 CIN3 59 hippocampal atrophy 59 oncologic outcomes 59 perioperative mortality 59 nonfasting triglyceride levels 59 elevated triglycerides 59 HIV HCV coinfected 59 elevated ALT 59 vaginal hysterectomy 59 neuropathies 59 Androgen deprivation therapy 59 seminomas 59 angina pectoris 59 ALT elevations 59 endometriosis ovarian cysts 59 familial aggregation 59 postoperative atrial fibrillation 59 depressive symptoms 59 tibolone 59 transurethral 59 pelvic lymphadenectomy 59 diastolic BP 59 symptomatic VTE 59 osteopenic 59 CIMZIA ™ 59 levodopa therapy 59 dopaminergic therapy 59 tapentadol ER 59 coexisting illnesses 59 exploratory endpoints 59 clozapine Clozaril 59 ß blockers 59 pharmacological therapies 59 EXJADE 59 BENICAR HCT 59 sacral neuromodulation 59 onset seizures 59 gait disturbance 59 transurethral resection 59 leucopenia 59 corticosteroid dose 58 % CI #.#-#.# [005] 58 neoplasia 58 venous thromboembolic disease 58 subscale scores 58 transaminase elevations 58 secondary hypogonadism 58 multivariable adjusted 58 nocturnal enuresis 58 spirometric 58 euthymic patients 58 intima media thickness 58 inflammatory biomarkers 58 metabolic syndrome MetS 58 chronic periodontitis 58 gout flares 58 colorectal adenomas 58 perioperatively 58 adenomatous 58 Multivariate analyzes 58 GnRH agonist 58 CrCl 58 breast carcinoma 58 preoperatively 58 euthymic 58 logistic regression analyzes 58 ALA PDT 58 thyroid nodules 58 prostate cancer PCa 58 acne vulgaris 58 idiopathic Parkinson disease 58 Prostatitis 58 comorbid psychiatric 58 vesicoureteral reflux 58 proliferative diabetic retinopathy 58 Preoperative 58 analgesic efficacy 58 psychosocial functioning 58 NMIBC 58 prostate enlargement 58 coadministration 58 hypovitaminosis D 58 atypical antipsychotic medications 58 ultrasonographic 58 lipid parameters 58 P = .# 58 mammographic density 58 LV ejection fraction 58 LV hypertrophy 58 carotid atherosclerosis 58 gastro oesophageal reflux 58 pelvic organ prolapse 58 hypertrophic scars 58 affective psychosis 58 penile curvature 58 adrenal insufficiency 58 noncardiac 58 Low Testosterone 58 lumbar disk herniation 58 elevated CRP 58 periprocedural 58 EDSS scores 58 reflux disease 58 rheumatoid arthritis osteoarthritis ankylosing 58 PAOD 58 hepatocellular 58 lipid abnormalities 58 #F FDG PET 58 Irritable Bowel Syndrome IBS 58 anticholinergic medication 58 Polycystic ovary syndrome PCOS 58 atrioventricular block 58 HRCT 58 Aortic stenosis 58 URTI 58 nephrolithiasis 58 sonographic findings 58 bladder bowel 58 incontinence episodes 58 HER2 overexpression 58 extrapyramidal symptoms EPS 58 VTE prophylaxis 58 osteoporotic vertebral compression fractures 58 metabolic abnormalities 58 SCr 58 vulvodynia 58 irritative symptoms 58 clinically localized prostate 58 breast abscesses 58 nonfatal MI 58 arterial hypertension 58 somatic complaints 58 thromboprophylaxis 58 disk herniation 58 HeFH 58 umol L 58 comorbid illnesses 58 elevated creatinine 58 anovulation 58 AST ALT 58 pelvic prolapse 58 erectile dysfunction impotence 58 Relapsing Remitting Multiple Sclerosis 58 dysthymic disorder 58 PSADT 58 underwent radical prostatectomy 58 subscore 58 Detrol Detrol LA 58 atopic 58 alfuzosin 58 Enlarged prostate 58 PASI scores 58 Index CDAI 58 hormone therapy HT 58 overt hypothyroidism 58 vaginal estrogen 58 ATACAND 58 carotid plaques 58 lipid lowering therapy 58 MGUS 58 mL/min/#.# m 2 58 orthostatic hypotension 58 episodic migraine 58 metabolic parameters 58 Akathisia 58 VUR 58 diabetes mellitus 58 hypertensives 58 hypogonadal men 58 DEXA scan 58 paroxysmal AF 58 Chronic Heart Failure 58 Overactive Bladder OAB 58 urinary leakage 58 premenstrual dysphoric disorder 58 antimuscarinic 58 recurrent UTI 58 intravitreal injections 58 PMS symptoms 58 aromatase inhibitors AIs 58 renal dysfunction 58 oral antidiabetic medication 58 psychopathological symptoms 58 femoral neck fractures 58 Comorbid 58 hypoparathyroidism 58 psoriatic arthritis PsA 58 Postmenopausal 58 acute subacute 58 clinically meaningful reductions 58 CC genotype 58 fragility fractures 58 inotropic 58 Postoperative 58 muscle dysmorphia 58 nonpharmacologic 58 PSA nadir 58 Renal dysfunction 58 narcolepsy cataplexy 58 PHPT 58 lymphadenectomy 58 abnormal lipid 58 MMSE score 58 hypercholesterolaemia 58 primary ovarian insufficiency 58 inflammatory lesions 58 highest tertile 58 perioperative morbidity 57 recurrent preterm birth 57 Adenomas 57 ADPKD 57 menopausal hot flushes 57 MADRS score 57 DDP# 57 aldosterone antagonist 57 Sleep disturbances 57 TRUS 57 lipid elevations 57 SGRQ 57 hormone therapy estrogen 57 decompensated cirrhosis 57 non menstrual pelvic 57 mixed hyperlipidemia 57 metaplasia 57 TURBT 57 gadolinium enhanced 57 Acute Coronary Syndromes ACS 57 SHBG levels 57 arterial thickening 57 LNG IUS 57 mIU L 57 GH deficient 57 cytoreductive nephrectomy 57 pelvic pain 57 alanine aminotransferase 57 gastric adenocarcinoma 57 androgen excess 57 aged ≥ 57 prostate TURP 57 hypophosphatemia 57 nonoperative 57 nondiabetic patients 57 hematopoietic cancers 57 pCR 57 neurodevelopmental outcome 57 virologic response 57 urethral strictures 57 serum folate concentrations 57 HBeAg negative 57 albumin excretion 57 premenopause 57 desvenlafaxine succinate 57 sensory neuropathy 57 atopic eczema 57 endoscopic ultrasonography 57 VIIBRYD 57 multivariate adjustment 57 triiodothyronine 57 SGOT 57 multivariate Cox 57 migraineurs 57 Hepatotoxicity 57 metabolite concentrations 57 tibiofemoral 57 neurologic complications 57 frequent awakenings 57 isolated systolic hypertension 57 disc degeneration 57 contralateral breast 57 generalized tonic clonic seizures 57 ALISTA 57 unipolar depression 57 thyroidectomy 57 renal scarring 57 THIS STUDY 57 conventional antipsychotics 57 serologically active patients 57 clinicopathologic 57 acromegalic patients 57 elevated IOP 57 Major Depressive Disorder MDD 57 hydroxyvitamin D levels 57 NIH CPSI 57 lymphocytosis 57 adenoma recurrence 57 cognitive impairment 57 cranial irradiation 57 urinary calcium 57 colorectal neoplasia 57 symptomatology 57 cryptorchidism 57 myopia nearsightedness 57 pyridostigmine 57 left ventricular hypertrophy 57 Ischemic 57 Epidemiologic studies 57 ALT elevation 57 hypocalcemia 57 habitual snoring 57 hyperlipidaemia 57 anticonvulsant medications 57 myalgias 57 Spinal manipulation 57 lobular breast cancer 57 Skin sterol 57 co morbidities 57 Severe Primary IGFD 57 nonalcoholic steatohepatitis 57 INVEGA ® 57 progressive dyspnea 57 myeloproliferative diseases 57 subscales 57 Critical Limb Ischemia CLI 57 node metastases 57 intermittent claudication 57 liver fibrosis 57 abnormal ejaculation 57 angiographically 57 neurosensory 57 antibiotic prophylaxis 57 hypercholesterolemia 57 AGILECT R 57 autoantibody positive 57 Logistic regression analysis 57 Inhibin B 57 antithrombotic therapy 57 INCB# [003] 57 Adjunctive 57 cognitive dysfunction 57 suicide attempters 57 daytime somnolence 57 cystoscopic 57 CTEPH 57 papillary thyroid carcinoma 57 risperidone Risperdal 57 hemorrhagic complications 57 neurologic symptoms 57 somatization disorder 57 parathyroid 57 ragweed allergic 57 vestibular dysfunction 57 LYSTEDA 57 contralateral breast cancer 57 preoperative diagnosis 57 esophagogastric 57 glomerular filtration 57 premenstrual syndrome 57 hyperparathyroidism 57 neuroleptic 57 adrenal function 57 ovarian hormones 57 truncal 57 menstrual bleeding 57 anovulatory infertility 57 EBUS FNA 57 hepatic fibrosis 57 serum prostate 57 sexual dysfunction 57 subsyndromal depression 57 hepatotoxicity 57 urinary albumin excretion 57 Preoperatively 57 histologically proven 57 Chemotherapy induced 57 Sexual dysfunction 57 testicular tumors 57 perfusion abnormalities 57 overactive bladder syndrome 57 androgenetic alopecia 57 hepatic enzymes 57 CIN2 + 57 osteoporotic vertebral fractures 57 subclinical hyperthyroidism 57 pheochromocytoma 57 CYP#D# inhibitor 57 unfavorable prognostic 57 SIADH 57 #.#ng/ml 57 musculoskeletal pain 57 prostate carcinogenesis 57 generalized seizures 57 depressive disorders 57 conditional logistic regression 57 paroxetine Paxil 57 white matter hyperintensities 57 euthyroid 57 aripiprazole 57 N telopeptide 57 urodynamics 57 SSRI SNRI 57 serum triglycerides 57 esophageal squamous cell carcinoma 57 cardiovascular mortality 57 anticholinergics 57 microvascular disease 57 Bacterial vaginosis 57 serum retinol 57 neurologic deficits 57 postoperative pulmonary 57 hypothalamic amenorrhea 57 polycystic ovarian syndrome PCOS 57 CARDIA 57 radiotherapy RT 57 Suicidal ideation 57 angiotensin converting enzyme inhibitor 57 interpersonal psychotherapy 57 dentinal hypersensitivity 57 postoperative chemotherapy 57 clinically meaningful improvements 57 somatostatin analogs 57 lower extremity amputation 57 QTc 57 grade squamous intraepithelial 57 systolic BP 57 % CI #.#-#.# [006] 57 bulimia nervosa 57 APOE e4 57 denervation 57 PGAD 57 urinary frequency 57 thiopurine 57 extensive metabolizers 57 GERD 57 adenomyosis 57 urethritis 57 elevated LDL cholesterol 57 IBS C 57 tricyclic antidepressants 57 serum creatinine levels 57 Overactive Bladder 57 myofascial pain syndrome 57 T1 weighted images 57 Gynecomastia 57 hypersomnia 57 preoperative 57 pathophysiological mechanisms 57 sinus node dysfunction 57 Mitral Regurgitation 57 nodal metastasis 57 induce orthostatic hypotension 57 severe obstructive sleep 57 coronary microvascular 57 thyrotropin 57 salmeterol fluticasone 57 subsyndromal 57 serum uric acid 57 Urinary incontinence 57 erectile difficulties 57 autistic traits 57 APOE genotype 57 adenoidectomy 57 elevated LDH 57 protein excretion 57 parous women 57 intraoperative complications 57 risk reducing salpingo 57 generalized epilepsy 57 Hashimoto thyroiditis 57 RLAI 57 PDE5 inhibitor 57 COPD exacerbation 57 diabetic gastroparesis 57 diarrhea predominant IBS 57 Scale EDSS score 57 hepatic metastases 57 % CI #.#-#.# [003] 57 multivariable analysis 57 androgen suppression therapy 57 ejaculatory function 57 Univariate analysis 57 graft occlusion 57 polyp recurrence 57 postmenopausal estrogen 56 sulfasalazine 56 neovascular glaucoma 56 systolic dysfunction 56 Generalised Anxiety Disorder 56 analgesic medications 56 Mood disorders 56 renal insufficiency 56 nonpsychiatric 56 Vaginal dryness 56 osteoporotic fracture 56 Irritable bowel syndrome 56 aromatase inhibitor therapy 56 HbA 1c levels 56 multivariate logistic regression 56 vitamin D inadequacy 56 medroxyprogesterone 56 Toxicities 56 affective disorder 56 primary dysmenorrhoea 56 atherothrombotic disease 56 myomas 56 myocardial ischemia 56 GBA mutations 56 aortic atherosclerosis 56 irregular menstrual periods 56 nonpregnant women 56 Pharmacologic 56 prostate cancer CRPC 56 transaminases 56 vWD 56 lipid lowering medications 56 prolactin elevation 56 hyperprolactinemia 56 corticosteroid induced 56 daytime alertness 56 chronic myocardial ischemia 56 cytoreductive surgery 56 nausea vomiting headache 56 oophorectomy 56 esophageal reflux 56 prostate carcinoma 56 TMJ disorders 56 tipranavir r 56 Poisson regression 56 PFPS 56 vardenafil Levitra 56 neoplasias 56 Chronic Migraine 56 Catheter Associated 56 neurocognitive functioning 56 benign breast 56 osteopathic manipulation 56 Chronic pelvic 56 CaP 56 distal colon cancer 56 arterial calcification 56 postmenopausal hormones 56 #q# deletion syndrome 56 systemic lupus erythematosus SLE 56 delayed gastric emptying 56 pulmonary dysfunction 56 gastroduodenal 56 mu opioid 56 urine cytology 56 noninfectious uveitis 56 epidural analgesia 56 lymph node enlargement 56 chronic renal disease 56 perianal 56 posttraumatic 56 metastatic bone 56 cystectomy 56 dyslipidemias 56 liver resection 56 temporal arteritis 56 lumbar spine BMD 56 T2D 56 subgroup analyzes 56 posterior vitreous detachment 56 C. trachomatis 56 constipation nausea 56 citalopram Celexa 56 somatostatin analog 56 pain syndromes 56 nonobstructive 56 orchitis 56 FDG PET imaging 56 carotid plaque 56 bazedoxifene conjugated estrogens 56 fluoxetine paroxetine 56 nonobese 56 multiple logistic regression 56 proliferative retinopathy 56 Neovascular AMD 56 renal cell carcinomas 56 pyloric stenosis 56 corticosteroid injection 56 enlarged prostates 56 Leydig cell 56 lichen planus 56 pulmonary metastases 56 Interpersonal psychotherapy 56 AGILECT ® 56 atherosclerotic vascular disease 56 bisphosphonate therapy 56 Postoperative complications 56 hemodilution 56 AA Amyloidosis 56 intravenous bisphosphonates 56 hypoperfusion